CNN’s John Berman speaks with Albert Bourla, CEO of Pfizer, as his company announced its experimental pill designed to fight coronavirus, reduced the risk of hospitalization and death for high-risk patients taking part in a trial of the drug.
Abbott Laboratories has announced that specific models of its glucose monitors may produce inaccurate readings, a malfunction linked to seven fatalities and more than 700 injuries globally.